• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催乳素与卵巢癌之间的联系。

Connections between prolactin and ovarian cancer.

机构信息

Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.

Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.

出版信息

PLoS One. 2021 Aug 6;16(8):e0255701. doi: 10.1371/journal.pone.0255701. eCollection 2021.

DOI:10.1371/journal.pone.0255701
PMID:34358244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8345882/
Abstract

Ovarian cancer (OC) is characterized by a high morbidity and mortality, highlighting a great need for a better understanding of biological mechanisms that affect OC progression and improving its early detection methods. This study investigates effects of prolactin (PRL) on ovarian cancer cells, analyzes PRL receptors (PRLR) in tissue micro arrays and relates PRLR expression to survival of ovarian cancer. A database, composed of transcript profiles from OC, was searched for PRLR expression and results were put in relation to survival. Expression of PRLR in OC tissue sections and OC cell lines SKOV3, OV2008 and OVSAHO was assessed using immunohistochemistry, western blots and quantitative real-time PCR. The biological function of PRLR was evaluated by proliferation, colony formation and wound healing assays. Levels of PRLR mRNA are related to survival; in epithelial OC a high PRLR mRNA expression is related to a shorter survival. Analysis of a tissue micro array consisting of 84 OC showed that 72% were positive for PRLR immuno-staining. PRLR staining tended to be higher in OC of high grade tumors compared to lower grades. PRLR mRNA and protein can further be detected in OC cell lines. Moreover, in vitro treatment with PRL significantly activated the JAK/STAT pathway. PRLR expression is associated with OC survivals. PRL and its receptor may play an onco-modulatory role and promote tumor aggressiveness in OC. Alternatively, increased PRLR levels may form a base for the development of PRLR antagonist or PRLR antagonist-drug conjugate to increase selective uptake of anti-cancer drugs.

摘要

卵巢癌(OC)的发病率和死亡率均较高,这突出表明需要更好地了解影响 OC 进展的生物学机制,并改进其早期检测方法。本研究调查了催乳素(PRL)对卵巢癌细胞的影响,分析了组织微阵列中的 PRL 受体(PRLR),并将 PRLR 表达与卵巢癌的生存相关联。搜索了包含 OC 转录谱的数据库,以寻找 PRLR 表达,并将结果与生存相关联。使用免疫组织化学,Western blot 和定量实时 PCR 评估 OC 组织切片和 OC 细胞系 SKOV3、OV2008 和 OVSAHO 中的 PRLR 表达。通过增殖,集落形成和划痕愈合测定评估 PRLR 的生物学功能。PRLR mRNA 的水平与生存有关;在上皮 OC 中,高 PRLR mRNA 表达与较短的生存时间相关。对包含 84 例 OC 的组织微阵列进行分析表明,72%的 OC 对 PRLR 免疫染色呈阳性。与低等级肿瘤相比,高等级肿瘤的 PRLR 染色倾向更高。还可以在 OC 细胞系中进一步检测到 PRLR mRNA 和蛋白。此外,PRL 体外处理可显著激活 JAK/STAT 途径。PRLR 表达与 OC 存活相关。PRL 及其受体可能在 OC 中发挥致癌调节作用,并促进肿瘤侵袭性。或者,PRLR 水平的增加可能为开发 PRLR 拮抗剂或 PRLR 拮抗剂-药物偶联物奠定基础,以增加抗癌药物的选择性摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/33ea1f2e7ab2/pone.0255701.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/2d4cc011afdd/pone.0255701.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/6b137a02e305/pone.0255701.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/39e34d72242c/pone.0255701.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/f0a5e4595bd2/pone.0255701.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/d43f7904f8f6/pone.0255701.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/33ea1f2e7ab2/pone.0255701.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/2d4cc011afdd/pone.0255701.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/6b137a02e305/pone.0255701.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/39e34d72242c/pone.0255701.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/f0a5e4595bd2/pone.0255701.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/d43f7904f8f6/pone.0255701.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/8345882/33ea1f2e7ab2/pone.0255701.g006.jpg

相似文献

1
Connections between prolactin and ovarian cancer.催乳素与卵巢癌之间的联系。
PLoS One. 2021 Aug 6;16(8):e0255701. doi: 10.1371/journal.pone.0255701. eCollection 2021.
2
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.二苯丁基哌啶类抗精神病药物通过抑制催乳素受体信号通路抑制胰腺导管腺癌在小鼠中的生长。
Gastroenterology. 2020 Apr;158(5):1433-1449.e27. doi: 10.1053/j.gastro.2019.11.279. Epub 2019 Nov 29.
3
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.催乳素受体介导 HOXA1 刺激的乳腺癌细胞致癌性。
Int J Oncol. 2012 Dec;41(6):2285-95. doi: 10.3892/ijo.2012.1660. Epub 2012 Oct 15.
4
Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.催乳素增加卵巢癌细胞的存活和迁移:催乳素受体类型的重要性和 S179D 和 G129R 受体拮抗剂的治疗潜力。
Cancer Lett. 2011 Nov 1;310(1):101-8. doi: 10.1016/j.canlet.2011.06.014. Epub 2011 Jun 25.
5
Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.催乳素通过雌激素受体α(ERα)与信号转导和转录激活因子5(STAT5)之间的相互作用,转录激活其通用启动子,从而诱导乳腺癌细胞中其同源受体的上调。
Oncotarget. 2014 Oct 15;5(19):9079-91. doi: 10.18632/oncotarget.2376.
6
Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.内源性催乳素和细胞周期蛋白依赖性激酶7在雌激素诱导的乳腺癌细胞催乳素受体上调中的重要作用。
Oncotarget. 2017 Apr 18;8(16):27353-27363. doi: 10.18632/oncotarget.16040.
7
The role of prolactin receptor in GH signaling in breast cancer cells.催乳素受体在乳腺癌细胞生长激素信号传导中的作用。
Mol Endocrinol. 2013 Feb;27(2):266-79. doi: 10.1210/me.2012-1297. Epub 2012 Nov 28.
8
Alpha-adrenoceptor agonists trigger prolactin signaling in breast cancer cells.α-肾上腺素能受体激动剂可触发乳腺癌细胞中的催乳素信号传导。
Cell Signal. 2017 Jun;34:76-85. doi: 10.1016/j.cellsig.2017.03.003. Epub 2017 Mar 14.
9
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.催乳素受体的刺激可诱导多形性胶质母细胞瘤中STAT-5磷酸化和细胞侵袭。
Oncotarget. 2016 Nov 29;7(48):79572-79583. doi: 10.18632/oncotarget.12840.
10
Seasonal patterns of prolactin, prolactin receptor, and STAT5 expression in the ovaries of wild ground squirrels (<em>Citellus dauricus</em> Brandt).野生草原黄鼠(<em>Citellus dauricus</em> Brandt)卵巢中催乳素、催乳素受体和 STAT5 表达的季节性变化。
Eur J Histochem. 2023 Oct 2;67(4):3825. doi: 10.4081/ejh.2023.3825.

引用本文的文献

1
Ovarian cancer causing hyperprolactinemia: A case report and narrative review.卵巢癌导致高催乳素血症:一例病例报告及叙述性综述
Medicine (Baltimore). 2025 Feb 7;104(6):e40585. doi: 10.1097/MD.0000000000040585.
2
Prognostic significance of CNNM4 in ovarian cancer: a comprehensive bioinformatics analysis.CNNM4在卵巢癌中的预后意义:一项全面的生物信息学分析
Front Oncol. 2024 Dec 3;14:1483425. doi: 10.3389/fonc.2024.1483425. eCollection 2024.
3
Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer.

本文引用的文献

1
Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer.人巨细胞病毒感染诱导卵巢癌中催乳素和催乳素受体的高表达。
Biology (Basel). 2020 Feb 27;9(3):44. doi: 10.3390/biology9030044.
2
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.STAT3和STAT5信号通路激活在上皮性卵巢癌进展中的作用:机制与治疗机遇
Cancers (Basel). 2019 Dec 19;12(1):24. doi: 10.3390/cancers12010024.
3
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation.
脂肪细胞衍生的外泌体促进卵巢癌细胞侵袭并挑战紫杉醇疗效。
Cell Commun Signal. 2024 Sep 16;22(1):443. doi: 10.1186/s12964-024-01806-4.
4
Prolactin Regulates Ovine Ovarian Granulosa Cell Apoptosis by Affecting the Expression of Gene.催乳素通过影响基因的表达来调节绵羊卵巢颗粒细胞凋亡。
Int J Mol Sci. 2023 Jun 17;24(12):10269. doi: 10.3390/ijms241210269.
5
Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?重新评估孕激素在卵巢癌中的作用:孕激素总是保护性的吗?
Endocr Rev. 2023 Nov 9;44(6):1029-1046. doi: 10.1210/endrev/bnad018.
6
The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy.信号转导和转录激活因子在卵巢癌中的作用:探索其治疗潜力
Cancers (Basel). 2023 Apr 26;15(9):2485. doi: 10.3390/cancers15092485.
7
Involvement of the PRL-PAK1 Pathway in Cancer Cell Migration.催乳素- p21激活激酶1信号通路在癌细胞迁移中的作用
Cancer Diagn Progn. 2023 Jan 3;3(1):17-25. doi: 10.21873/cdp.10174. eCollection 2023 Jan-Feb.
8
PRLR and CACNA2D1 Impact the Prognosis of Breast Cancer by Regulating Tumor Immunity.催乳素受体(PRLR)和电压依赖性钙通道辅助亚基α2δ-1(CACNA2D1)通过调节肿瘤免疫影响乳腺癌预后。
J Pers Med. 2022 Dec 19;12(12):2086. doi: 10.3390/jpm12122086.
9
Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression.长链非编码 RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 轴调控结直肠癌进展。
Bioengineered. 2022 Jan;13(1):12-26. doi: 10.1080/21655979.2021.1976894.
一种体内半衰期延长的催乳素受体拮抗剂可阻止 STAT5 磷酸化。
PLoS One. 2019 May 7;14(5):e0215831. doi: 10.1371/journal.pone.0215831. eCollection 2019.
4
miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells.miR-205-5p介导的PTEN下调促进C13K人卵巢癌细胞的顺铂耐药
Front Genet. 2018 Nov 19;9:555. doi: 10.3389/fgene.2018.00555. eCollection 2018.
5
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.EGFRvIII-Stat5 信号增强胶质母细胞瘤细胞迁移和存活。
Mol Cancer Res. 2018 Jul;16(7):1185-1195. doi: 10.1158/1541-7786.MCR-18-0125. Epub 2018 May 3.
6
Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis.深入了解内分泌系统和免疫系统:泌乳素在类风湿关节炎和银屑病关节炎中的炎症作用综述
Front Immunol. 2017 Jun 23;8:720. doi: 10.3389/fimmu.2017.00720. eCollection 2017.
7
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers.新型抗泌乳素受体(PRLR)抗体药物偶联物 REGN2878-DM1 在 PRLR 阳性乳腺癌中的临床前活性。
Mol Cancer Ther. 2017 Jul;16(7):1299-1311. doi: 10.1158/1535-7163.MCT-16-0839. Epub 2017 Apr 4.
8
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
9
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.催乳素受体的刺激可诱导多形性胶质母细胞瘤中STAT-5磷酸化和细胞侵袭。
Oncotarget. 2016 Nov 29;7(48):79572-79583. doi: 10.18632/oncotarget.12840.
10
Prolactin receptor in breast cancer: marker for metastatic risk.乳腺癌中的催乳素受体:转移风险标志物
J Mol Endocrinol. 2016 Nov;57(4):R153-R165. doi: 10.1530/JME-16-0150. Epub 2016 Sep 22.